Seer Inc.

AI Score

0

Unlock

2.34
0.05 (2.18%)
At close: Jan 15, 2025, 12:06 PM
undefined%
Bid 2.33
Market Cap 137.78M
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) -1.3
PE Ratio (ttm) -1.8
Forward PE n/a
Analyst Hold
Ask 2.34
Volume 49,875
Avg. Volume (20D) 233,418
Open 2.31
Previous Close 2.29
Day's Range 2.29 - 2.37
52-Week Range 1.51 - 2.63
Beta undefined

About SEER

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover...

Industry Biotechnology
Sector Healthcare
IPO Date Dec 4, 2020
Employees 147
Stock Exchange NASDAQ
Ticker Symbol SEER

Analyst Forecast

According to 1 analyst ratings, the average rating for SEER stock is "Hold." The 12-month stock price forecast is $3, which is an increase of 28.40% from the latest price.

Buy 0.00%
Hold 100.00%
Sell 0.00%
Stock Forecasts

Next Earnings Release

Seer Inc. is scheduled to release its earnings on Feb 27, 2025, during market hours.
Analysts project revenue of $3.95M, reflecting a -11% YoY shrinking and earnings per share of -0.37, making a 32.14% increase YoY.